Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,513 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined sodium-glucose cotransporter-2 inhibitor and glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes and chronic kidney disease.
RECAP study group; Tsukamoto S, Kobayashi K, Toyoda M, Tone A, Kawanami D, Suzuki D, Tsuriya D, Machimura H, Shimura H, Wakui H, Takeda H, Yokomizo H, Takeshita K, Chin K, Kanasaki K, Miyauchi M, Saburi M, Morita M, Yomota M, Kimura M, Hatori N, Nakajima S, Ito S, Murata T, Matsushita T, Furuki T, Hashimoto T, Umezono T, Muta Y, Takashi Y, Tamura K. RECAP study group, et al. Among authors: morita m. Diabetes Obes Metab. 2024 May 19. doi: 10.1111/dom.15652. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 38764356
Bag1 protein loss sensitizes mouse embryonic fibroblasts to glutathione depletion.
Inose-Maruyama A, Irokawa H, Takeda K, Taguchi K, Morita M, Yamamoto M, Sasaki M, Kuge S. Inose-Maruyama A, et al. Among authors: morita m. Cell Stress Chaperones. 2024 May 17:S1355-8145(24)00075-0. doi: 10.1016/j.cstres.2024.05.003. Online ahead of print. Cell Stress Chaperones. 2024. PMID: 38763404 Free article.
Mitochondrial ACSS1-K635 acetylation knock-in mice exhibit altered metabolism, cell senescence, and nonalcoholic fatty liver disease.
Xu G, Quan S, Schell J, Gao Y, Varmazyad M, Sreenivas P, Cruz D, Jiang H, Pan M, Han X, Palavicini JP, Zhao P, Sun X, Marchant ED, Rasmussen BB, Li G, Katsumura S, Morita M, Munkácsy E, Horikoshi N, Chocron ES, Gius D. Xu G, et al. Among authors: morita m. Sci Adv. 2024 May 17;10(20):eadj5942. doi: 10.1126/sciadv.adj5942. Epub 2024 May 17. Sci Adv. 2024. PMID: 38758779 Free PMC article.
The efficacy and safety of anamorelin among patients with diabetes.
Ando K, Naito T, Hamauchi S, Miura K, Nishibori Y, Tonsho A, Matsuda S, Morita M, Sekikawa M, Doshita K, Kodama H, Yabe M, Morikawa N, Iida Y, Mamesaya N, Kobayashi H, Ryo K, Wakuda K, Ono A, Kenmotsu H, Murakami H, Yamazaki K, Takahashi T. Ando K, et al. Among authors: morita m. Int J Clin Oncol. 2024 May 9. doi: 10.1007/s10147-024-02546-8. Online ahead of print. Int J Clin Oncol. 2024. PMID: 38722487
A curious Takotsubo cardiomyopathy after COVID-19.
Kinoshita H, Morita M, Maeda S, Kanegawa M, Sumimoto Y, Masada K, Shimonaga T, Sugino H. Kinoshita H, et al. Among authors: morita m. IDCases. 2024 Apr 15;36:e01958. doi: 10.1016/j.idcr.2024.e01958. eCollection 2024. IDCases. 2024. PMID: 38681073 Free PMC article.
Relationship between 2nd-generation angiotensin receptor blockers and the risk of hypotension in COVID-19 patients admitted to hospital.
Yoshihara F, Matsuzawa Y, Nakatsuka K, Kirigaya J, Takeuchi I, Kimura K, Konishi M, Tamura K, Fukui K, Tsukahara K, Shimizu H, Iwabuchi K, Yamada Y, Saka K, Sato Y, Ogawa M, Hayakawa K, Ohmagari N, Ikeda S, Akao M, Shimomura H, Kihara Y, Yoshimoto A, Morita M, Kumada N, Ogata S, Nishimura K, Arisato T, Matsuo M, Kishida M, Yasuda S, Ogawa H. Yoshihara F, et al. Among authors: morita m. Hypertens Res. 2024 Apr 26. doi: 10.1038/s41440-024-01682-y. Online ahead of print. Hypertens Res. 2024. PMID: 38664510
3,513 results